Skip to main content
. 2012 Oct 16;8(5):841–847. doi: 10.5114/aoms.2012.31133

Figure 1.

Figure 1

Yearly increases in BMD (mean ± SD) in FHA patients subjected to 4-year EP treatment (group A) stratified depending on PvuII polymorphisms of ER-α